ARCHIVES

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

House Still Sees Problems In NIH Financial Management

July 5, 1991

NCI Supercomputer Operations To Start In April

November 15, 1985

In Brief: NCI To Go Along With NCAB on Keeping Clinical Education Program Alive; Cal Baldwin Retires

February 28, 1986

Drug Approved in Europe For Pediatric Cancer Patients

April 24, 2009

DCT Bard Okays Concepts for BRMP Contract Programs

June 22, 1984

In Brief: Job Discrimination Survey Report Not Ready Until Next Month; Saccharin Date Extended

September 17, 1977